Ottawa, August 4, 2017 The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada and its member companies support policies and practices that place […]
This strategic partnership will identify ways to attract investment, expand research, improve patient access to medicines and, ultimately…
Innovative Medicines Canada welcomes the life sciences strategy, the positioning of Quebec and continued work to improve access to medicines for Quebec patients. Montreal, May 5, 2017 – Innovative Medicines Canada […]
Toronto, April 27, 2017 – In response to the budget tabled by Ontario Finance Minister Charles Sousa, Innovative Medicines Canada welcomes the Government of Ontario’s initiative to launch OHIP+, a […]
We welcome the commitments made to Quebec’s life sciences ecosystem in the 2017-2018 budget. [Available in French only.]
Ottawa, March 22, 2017– Innovative Medicines Canada President Pamela Fralick issued the following statement in response to the tabling of the federal budget: “Innovative Medicines Canada is pleased to see […]
Statement Ottawa, March 7, 2017 – The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada is concerned by recent legislative initiatives in the […]
Canada’s innovative pharmaceutical companies invest more than $1-billion every year in research and development to create new innovative medicines and vaccines that save or improve the lives of Canadian patients.
In response to CBC’s the fifth estate, Innovative Medicines Canada issued the following statement:
Innovative Medicines Canada has sent a letter of concern to the publisher of the Report on Business magazine and the Globe and Mail regarding the incorrect and misleading article entitled […]
